Back to Peptides
ApprovedApproved (Ozempic)

Semaglutide for Parkinson's Disease

Semaglutide may help with Parkinson's Disease through its GHRH agonist mechanisms, potentially supporting weight loss.

About Parkinson's Disease

Parkinson's Disease is a neurological condition characterized by tremors and stiffness. Conventional treatments include levodopa, dopamine agonists.

Common Symptoms

tremorsstiffnessbalance problems

Conventional Treatments

  • levodopa
  • dopamine agonists
  • physical therapy

How Semaglutide May Help

Semaglutide works through GLP-1 agonist to support weight loss. Current research status: Approved.

Mechanisms of Action

GLP-1 agonist

Potential Benefits

  • weight loss
  • blood sugar control
  • cardiovascular benefits

Research Status & Legal Information

Research Status

Approved

Legal Status (Australia)

Approved (Ozempic)

Medical Disclaimer

This information is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare practitioner before starting any peptide therapy.

Potential Side Effects

  • nausea
  • vomiting
  • diarrhea
Semaglutide for Parkinson's Disease | Varney Health